Advancing Antibody Therapeutics to the Clinic
The Oncology Stream at PEGS is back to share what is new and exciting in the fight against cancer, and the antibody developments that are leading the charge. Drug discovery in oncology has relied on antibodies as a tool to determine therapeutic success.
Bispecific antibodies, cell engagers, ADCs, nanobodies and combinatorial therapies are being explored to improve targeted therapy and drug delivery. This year, we are adding a new track on Emerging Targets for Oncology & Beyond which will look
at hot targets including intracellular and recycled targets and novel pathways. Together, the 3 conferences in this stream will present a comprehensive look at strategies driving toward clinical success.
Antibodies for Cancer Therapy
Driving Clinical Success in Antibody Drug Conjugates
Emerging Targets and Novel Approaches for Oncology & Beyond